買掛金、研究開発費、当期純利益他2件
- 【期間】
| 年度 | 買掛金 | 研究開発費 | 当期純利益 | 売上債権売却損 | 投資有価証券償還損 |
|---|
| 2008/03 | 152億 | | - | | - | | - | | - | |
| 2009/03 | 157億 | +3.5% | - | | - | | 91百万 | | 226百万 | |
| 2010/03 | 155億 | -1.4% | - | | - | | 70百万 | -23.1% | - | |
| 2011/03 | 187億 | +20.2% | - | | 29.3億 | | 35百万 | -50% | - | |
| 2012/03 | 216億 | +16% | - | | 40.9億 | +39.6% | 13百万 | -62.9% | - | |
| 2013/03 | 303億 | +40% | 19億 | | 21億 | -48.6% | 4百万 | -69.2% | - | |
| 2014/03 | 225億 | -25.8% | 19.4億 | +2.1% | 29.2億 | +38.8% | - | | - | |
| 2015/03 | 238億 | +5.9% | 18.6億 | -4.3% | 39.8億 | +36.3% | - | | - | |
| 2016/03 | 203億 | -14.7% | 17.7億 | -4.8% | 57.2億 | +43.9% | - | | - | |
| 2017/03 | 234億 | +15.2% | 18.7億 | +5.8% | 80.7億 | +41.1% | - | | - | |
| 2018/03 | 266億 | +13.7% | 21.6億 | +15.3% | 73.9億 | -8.4% | - | | - | |
| 2019/03 | 242億 | -9.1% | 23億 | +6.6% | 94.8億 | +28.3% | - | | - | |
| 2020/03 | 246億 | +1.8% | 23.4億 | +1.9% | 85億 | -10.4% | - | | - | |
| 2021/03 | 293億 | +19.1% | 25億 | +6.5% | 81.4億 | -4.2% | - | | - | |
| 2022/03 | 329億 | +12.2% | 27億 | +8.3% | 87.3億 | +7.3% | - | | - | |
| 2023/03 | 395億 | +20.2% | 31.3億 | +15.8% | 113億 | +29.6% | - | | - | |
| 2024/03 | 346億 | -12.4% | 35.2億 | +12.5% | 156億 | +38% | - | | - | |
